562 related articles for article (PubMed ID: 10326692)
21. Randomized study of chemotherapy/radiation therapy combinations for favorable patients with locally advanced inoperable nonsmall cell lung cancer: Radiation Therapy Oncology Group (RTOG) 92-04.
Komaki R; Scott C; Ettinger D; Lee JS; Fossella FV; Curran W; Evans RF; Rubin P; Byhardt RW
Int J Radiat Oncol Biol Phys; 1997 Apr; 38(1):149-55. PubMed ID: 9212017
[TBL] [Abstract][Full Text] [Related]
22. Pre-operative chemoradiotherapy in non-small cell lung cancer stage III patients. Feasibility, toxicity and long-term results of a phase II study.
Favaretto A; Paccagnella A; Tomio L; Sartori F; Cipriani A; Zuin R; Reffosco L; Calabro F; Rea F; Ghiotto C; Chiarion-Sileni V; Oniga F; Loreggian L; Fiorentino MV
Eur J Cancer; 1996 Nov; 32A(12):2064-9. PubMed ID: 9014746
[TBL] [Abstract][Full Text] [Related]
23. A phase I/II trial of neoadjuvant chemotherapy with cisplatin and vinorelbine followed by accelerated irradiation for patients with inoperable nonsmall cell lung carcinoma.
Viallet J; Brassard MA; Souhami L; Ayoub J; Del Vecchio P; Kreisman H; Guerra J; Gruber J; Langleben A; Hohneker J; Rousseau P
Cancer; 1999 Jun; 85(12):2562-9. PubMed ID: 10375103
[TBL] [Abstract][Full Text] [Related]
24. Paclitaxel in combination chemotherapy with radiotherapy in patients with unresectable stage III non-small-cell lung cancer.
Greco FA; Stroup SL; Gray JR; Hainsworth JD
J Clin Oncol; 1996 May; 14(5):1642-8. PubMed ID: 8622083
[TBL] [Abstract][Full Text] [Related]
25. Irinotecan and cisplatin with concurrent split-course radiotherapy in locally advanced nonsmall-cell lung cancer: a multiinstitutional phase 2 study.
Fukuda M; Soda H; Fukuda M; Kinoshita A; Nakamura Y; Nagashima S; Takatani H; Tsukamoto K; Kohno S; Oka M
Cancer; 2007 Aug; 110(3):606-13. PubMed ID: 17577234
[TBL] [Abstract][Full Text] [Related]
26. Phase II study of concurrent chemotherapy and radiotherapy for unresectable stage III non-small-cell lung cancer: long-term follow-up results. Japan Clinical Oncology Group Protocol 8902.
Kubota K; Tamura T; Fukuoka M; Furuse K; Ikegami H; Ariyoshi Y; Kurita Y; Saijo N
Ann Oncol; 2000 Apr; 11(4):445-50. PubMed ID: 10847464
[TBL] [Abstract][Full Text] [Related]
27. Accelerated hyperfractionated radiotherapy combined with induction and concomitant chemotherapy for inoperable non-small-cell lung cancer--impact of total treatment time.
Nyman J; Bergman B; Mercke C
Acta Oncol; 1998; 37(6):539-45. PubMed ID: 9860311
[TBL] [Abstract][Full Text] [Related]
28. A phase III randomized trial of combined chemoradiotherapy versus radiotherapy alone in locally advanced non-small-cell lung cancer.
Kim TY; Yang SH; Lee SH; Park YS; Im YH; Kang WK; Ha SH; Park CI; Heo DS; Bang YJ; Kim NK
Am J Clin Oncol; 2002 Jun; 25(3):238-43. PubMed ID: 12040280
[TBL] [Abstract][Full Text] [Related]
29. Cisplatin and vinorelbine followed by radiotherapy in the treatment of stage III-B non-small-cell lung cancer patients.
Felip E; Del Campo JM; Bodi R; Vera R; Casado S; Rubio D
Am J Clin Oncol; 1997 Aug; 20(4):404-6. PubMed ID: 9256899
[TBL] [Abstract][Full Text] [Related]
30. Sequential chemoradiation therapy with vinorelbine, ifosfamide, and cisplatin in stage IIIB non-small cell lung cancer: a phase II study.
Baldini E; Silvano G; Tibaldi C; Campoccia S; Cionini L; Conte P
Semin Oncol; 2000 Feb; 27(1 Suppl 1):28-32. PubMed ID: 10697041
[TBL] [Abstract][Full Text] [Related]
31. Phase I trial of concurrent thoracic radiation and continuous infusion cisplatin and etoposide in stage III non-small cell lung cancer.
Kalemkerian GP; Belzer K; Wozniak AJ; Gaspar LE; Valdivieso M; Kraut MJ
Lung Cancer; 1999 Sep; 25(3):175-82. PubMed ID: 10512128
[TBL] [Abstract][Full Text] [Related]
32. Mitomycin C, vinblastine, and carboplatin regimen in patients with nonsmall cell lung cancer. A phase II trial.
Paccagnella A; Favaretto A; Oniga F; Festi G; Lauro S; Morabito A; Ossana L; Sartore F; DePoli F; Fiorentino MV
Cancer; 1996 Oct; 78(8):1701-7. PubMed ID: 8859183
[TBL] [Abstract][Full Text] [Related]
33. Mitomycin, cisplatin, and vindesine followed by radiotherapy combined with cisplatin in stage III nonsmall cell lung cancer: long-term results.
Tejedor M; Valerdi JJ; López R; Domínguez MA; Arias F; Illarramendi JJ; Martínez E
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):813-8. PubMed ID: 7860393
[TBL] [Abstract][Full Text] [Related]
34. Oral vinorelbine and cisplatin as induction chemotherapy and concomitant chemo-radiotherapy in stage III non-small cell lung cancer: final results of an international phase II trial.
Krzakowski M; Provencio M; Utracka-Hutka B; Villa E; Codes M; Kuten A; Henke M; Lopez M; Bell D; Biti G; Merimsky O; Beorchia A; Riggi M; Caux NR; Pouget JC; Dubray B; David P
J Thorac Oncol; 2008 Sep; 3(9):994-1002. PubMed ID: 18758302
[TBL] [Abstract][Full Text] [Related]
35. A randomized study of high-dose split course radiotherapy preceded by high-dose chemotherapy versus high-dose radiotherapy only in locally advanced non-small-cell lung cancer. An EORTC Lung Cancer Cooperative Group trial.
Planting A; Helle P; Drings P; Dalesio O; Kirkpatrick A; McVie G; Giaccone G
Ann Oncol; 1996 Feb; 7(2):139-44. PubMed ID: 8777169
[TBL] [Abstract][Full Text] [Related]
36. Report of phase II trial of concurrent chemoradiotherapy with radical thoracic irradiation (60 Gy), infusional fluorouracil, bolus cisplatin and etoposide for clinical stage IIIB and bulky IIIA non-small cell lung cancer.
Langer CJ; Curran WJ; Keller SM; Catalano R; Fowler W; Blankstein K; Litwin S; Bagchi P; Nash S; Comis R
Int J Radiat Oncol Biol Phys; 1993 Jun; 26(3):469-78. PubMed ID: 8390421
[TBL] [Abstract][Full Text] [Related]
37. Rapidly alternating combination of cisplatin-based chemotherapy and hyperfractionated accelerated radiotherapy in split course for stage IIIA and stage IIIB non-small cell lung cancer: results of a phase I-II study by the GOTHA group. Group d'Oncologie Thoracique des Régions Alpines.
Alberto P; Mirimanoff RO; Mermillod B; Leyvraz S; Nagy-Mignotte H; Bolla M; Wellmann D; Moro D; Brambilla E
Eur J Cancer; 1995; 31A(3):342-8. PubMed ID: 7786599
[TBL] [Abstract][Full Text] [Related]
38. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.
Ariyoshi Y; Fukuoka M; Furuse K; Saijo N; Ikegami H; Nishiwaki Y; Tamura T; Shimoyama M; Suemasu K
Jpn J Clin Oncol; 1994 Oct; 24(5):275-81. PubMed ID: 7967106
[TBL] [Abstract][Full Text] [Related]
39. A phase II study of continuous concurrent thoracic radiotherapy in combination with mitomycin, vindesine and cisplatin in unresectable stage III non-small cell lung cancer.
Atagi S; Kawahara M; Hosoe S; Ogawara M; Kawaguchi T; Okishio K; Naka N; Sunami T; Mitsuoka S; Akira M
Lung Cancer; 2002 Apr; 36(1):105-11. PubMed ID: 11891041
[TBL] [Abstract][Full Text] [Related]
40. Induction chemotherapy plus high-dose radiotherapy versus radiotherapy alone in locally advanced unresectable non-small-cell lung cancer.
Crinò L; Latini P; Meacci M; Corgna E; Maranzano E; Darwish S; Minotti V; Santucci A; Tonato M
Ann Oncol; 1993 Dec; 4(10):847-51. PubMed ID: 8117604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]